Banner

Broecker ’83/IBRI build partnership for diabetes study

Broecker says the project should be complete in the second quarter.

David Broecker ’83, CEO of Indiana Biosciences Research (IBRI), is working to bring together several big Indiana industry names to work together on a major study on Type 2 diabetes:  Eli Lilly and Co, Roche Diagnostics Corp., Regenstrief Institute, and Indiana University School of Medicine.  Click here for the news story and to hear Dave talk about the project on Inside Indiana Business:  New IBRI Study ‘Essence of Big Data.

 

 

 

Photo courtesy of Inside Indiana Business.